New stock news | Yuexiang Pharmaceutical (688658.SH) Hong Kong IPO prospectus invalid

Zhimedia Finance APP learned that the Hong Kong stock prospectus submitted by Yuekang Pharmaceutical Group Co., Ltd. (referred to as Yuekang Pharmaceutical, 688658.SH) on December 29, 2025, expired after 6 months on June 29, 2026. CITIC Securities was its exclusive sponsor when submitting the application.